Researchers tracked genomic alterations detected in patient samples during tumor cell evolution in culture, in patient-derived xenograft (PDX) mouse models from the cultures, as well as before and after treatment in patients. The team reports that tumor progression was often driven by cancer-promoting genes, known as oncogenes, on extrachromosomal pieces of DNA.
from Top Health News – ScienceDaily http://bit.ly/2qUJO6x
from Tumblr http://bit.ly/2HmLZLp
No comments:
Post a Comment